Codon 72 polymorphism of TP53 gene is a novel prognostic marker for therapy in multiple myeloma

被引：6

作者：

Hattori, Yutaka ^{[1
]}

Ikeda, Yurika ^{[1
]}

Suzuki, Yuya ^{[1
]}

Ichikawa, Daiju ^{[1
]}

Matsushita, Maiko ^{[1
]}

机构：

[1] Keio Univ Fac Pharm, Div Clin Physiol & Therapeut, Tokyo, Japan

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2014年 / 165卷 / 05期

关键词：

multiple myeloma; codon 72 polymorphism of TP53; thalidomide; prognosis; LUNG-CANCER; P53; SUSCEPTIBILITY; ASSOCIATION; LEUKEMIA; GSTM1; RISK;

D O I：

10.1111/bjh.12784

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：728 / 731

页数：4

共 10 条

[1] The codon 72 polymorphic variants of p53 have markedly different apoptotic potential [J].

Dumont, P ;

Leu, JIJ ;

Della Pietra, AC ;

George, DL ;

Murphy, M .

NATURE GENETICS, 2003, 33 (03) :357-365

[2] MDM2 SNP309 and TP53 Arg72Pro interact to alter therapy-related acute myeloid leukemia susceptibility [J].

Ellis, Nathan A. ;

Huo, Dezheng ;

Yildiz, Ozlem ;

Worrillow, Lisa J. ;

Banerjee, Mekhala ;

Le Beau, Michelle M. ;

Larson, Richard A. ;

Allan, James M. ;

Onel, Kenan .

BLOOD, 2008, 112 (03) :741-749

[3] Single-institute phase 2 study of thalidomide treatment for refractory or relapsed multiple myeloma: Prognostic factors and unique toxicity profile [J].

Hattori, Yutaka ;

Okamoto, Shin-ichiro ;

Shimada, Naoki ;

Kakimoto, Tsunayuki ;

Morita, Kunihiko ;

Tanigawara, Yusuke ;

Ikeda, Yasuo .

CANCER SCIENCE, 2008, 99 (06) :1243-1250

[4] Association with TP53 codon 72 polymorphism and the risk of non-Hodgkin lymphoma [J].

Kim, Hee Nam ;

Yu, Li ;

Kim, Nan Young ;

Lee, Il-Kwon ;

Kim, Yeo-Kyeoung ;

Yang, Deok-Hwan ;

Lee, Je-Jung ;

Shin, Min-Ho ;

Park, Kyeong-Soo ;

Choi, Jin-Su ;

Kim, Hyeoung-Joon .

AMERICAN JOURNAL OF HEMATOLOGY, 2010, 85 (10) :822-824

[5]

Miller DP, 2002, CANCER RES, V62, P2819

[6] Poor clinical significance of p53 gene polymorphism in acute myeloid leukemia [J].

Nakano, Y ;

Naoe, T ;

Kiyoi, H ;

Kunishima, S ;

Minami, S ;

Miyawaki, S ;

Asou, N ;

Kuriyama, K ;

Saito, H ;

Ohno, R .

LEUKEMIA RESEARCH, 2000, 24 (04) :349-352

[7] GSTM1 and codon 72 P53 polymorphism in multiple myeloma [J].

Ortega, Manoela M. ;

Honma, Helen N. ;

Zambon, Lair ;

Lorand-Metze, Irene ;

Costa, Fernando F. ;

De Souza, Carmino A. ;

Lima, Carmen S. P. .

ANNALS OF HEMATOLOGY, 2007, 86 (11) :815-819

[8] Cancer Susceptibility Polymorphism of p53 at Codon 72 Affects Phosphorylation and Degradation of p53 Protein [J].

Ozeki, Chikako ;

Sawai, Yuichiro ;

Shibata, Tatsuhiro ;

Kohno, Takashi ;

Okamoto, Koji ;

Yokota, Jun ;

Tashiro, Fumio ;

Tanuma, Sei-ichi ;

Sakai, Ryuichi ;

Kawase, Tatsuya ;

Kitabayashi, Issay ;

Taya, Yoichi ;

Ohki, Rieko .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (20) :18251-18260

[9] Association of p53 codon 72 polymorphism with advanced lung cancer: the Arg allele is preferentially retained in tumours arising in Arg/Pro germline heterozygotes [J].

Papadakis, ED ;

Soulitzis, N ;

Spandidos, DA .

BRITISH JOURNAL OF CANCER, 2002, 87 (09) :1013-1018

[10] p53 codon 72 polymorphism and Hematological Cancer Risk: An Update Meta-Analysis [J].

Weng, Yu ;

Lu, Liqin ;

Yuan, Guorong ;

Guo, Jing ;

Zhang, Zhizhong ;

Xie, Xinyou ;

Chen, Guangdi ;

Zhang, Jun .

PLOS ONE, 2012, 7 (09)

← 1 →